Ildong Pharmaceutical Co., Ltd. (KRX: 249420)
South Korea
· Delayed Price · Currency is KRW 12,360
+210 (1.73%)
Nov 18, 2024, 1:00 PM KST
Ildong Pharmaceutical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Operating Revenue | 603,864 | 600,758 | 637,714 | 560,132 | 561,845 | 517,468 | Upgrade
|
| Other Revenue | -0 | -0 | - | -0 | - | - | Upgrade
|
| Revenue | 603,864 | 600,758 | 637,714 | 560,132 | 561,845 | 517,468 | Upgrade
|
| Revenue Growth (YoY) | -1.92% | -5.80% | 13.85% | -0.30% | 8.58% | 2.69% | Upgrade
|
| Cost of Revenue | 383,793 | 387,109 | 401,627 | 340,958 | 323,674 | 290,335 | Upgrade
|
| Gross Profit | 220,071 | 213,649 | 236,088 | 219,174 | 238,171 | 227,132 | Upgrade
|
| Selling, General & Admin | 161,770 | 165,051 | 190,252 | 171,296 | 164,598 | 178,366 | Upgrade
|
| Research & Development | 70,795 | 95,018 | 109,895 | 96,524 | 60,181 | 43,562 | Upgrade
|
| Other Operating Expenses | 1,238 | 1,216 | 3,814 | 1,087 | 1,454 | 961.97 | Upgrade
|
| Operating Expenses | 239,270 | 267,067 | 309,754 | 273,586 | 232,642 | 228,675 | Upgrade
|
| Operating Income | -19,199 | -53,418 | -73,666 | -54,412 | 5,529 | -1,542 | Upgrade
|
| Interest Expense | -16,404 | -14,725 | -9,788 | -10,556 | -4,669 | -5,226 | Upgrade
|
| Interest & Investment Income | 985.01 | 1,093 | 1,552 | 569.37 | 260.18 | 342.64 | Upgrade
|
| Earnings From Equity Investments | -0.73 | -0.36 | -0.54 | -1.67 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -769.64 | -748.46 | -475.09 | 168.49 | -771.47 | -99.41 | Upgrade
|
| Other Non Operating Income (Expenses) | -16,295 | -24,556 | -20,485 | -75,458 | 1,049 | -1,114 | Upgrade
|
| EBT Excluding Unusual Items | -51,684 | -92,354 | -102,862 | -139,690 | 1,397 | -7,639 | Upgrade
|
| Gain (Loss) on Sale of Investments | 439.72 | 439.72 | 2,325 | -862.82 | -5,222 | 84.34 | Upgrade
|
| Gain (Loss) on Sale of Assets | -2,501 | 1,133 | -282.22 | -101.53 | 2,029 | 1,891 | Upgrade
|
| Asset Writedown | -1,342 | -3,492 | -19,004 | -550.27 | -7,928 | -16,971 | Upgrade
|
| Pretax Income | -55,086 | -94,273 | -119,823 | -141,205 | -9,724 | -22,634 | Upgrade
|
| Income Tax Expense | -3,298 | -13,312 | 22,346 | -40,237 | 3,295 | -9,191 | Upgrade
|
| Earnings From Continuing Operations | -51,789 | -80,961 | -142,170 | -100,968 | -13,019 | -13,444 | Upgrade
|
| Minority Interest in Earnings | 3,109 | 2,033 | 584.6 | 1,263 | - | - | Upgrade
|
| Net Income | -48,679 | -78,928 | -141,585 | -99,705 | -13,019 | -13,444 | Upgrade
|
| Net Income to Common | -48,679 | -78,928 | -141,585 | -99,705 | -13,019 | -13,444 | Upgrade
|
| Shares Outstanding (Basic) | 28 | 27 | 26 | 24 | 24 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 28 | 27 | 26 | 24 | 24 | 24 | Upgrade
|
| Shares Change (YoY) | 3.05% | 2.61% | 10.76% | -0.00% | -0.02% | -0.01% | Upgrade
|
| EPS (Basic) | -1763.51 | -2920.01 | -5374.53 | -4191.88 | -547.34 | -565.08 | Upgrade
|
| EPS (Diluted) | -1783.29 | -2939.65 | -5379.82 | -4192.00 | -547.34 | -565.08 | Upgrade
|
| Free Cash Flow | -18,767 | -49,817 | -65,413 | -25,992 | 5,014 | 29,306 | Upgrade
|
| Free Cash Flow Per Share | -679.86 | -1843.01 | -2483.08 | -1092.76 | 210.79 | 1231.84 | Upgrade
|
| Gross Margin | 36.44% | 35.56% | 37.02% | 39.13% | 42.39% | 43.89% | Upgrade
|
| Operating Margin | -3.18% | -8.89% | -11.55% | -9.71% | 0.98% | -0.30% | Upgrade
|
| Profit Margin | -8.06% | -13.14% | -22.20% | -17.80% | -2.32% | -2.60% | Upgrade
|
| Free Cash Flow Margin | -3.11% | -8.29% | -10.26% | -4.64% | 0.89% | 5.66% | Upgrade
|
| EBITDA | 7,205 | -25,099 | -44,121 | -25,101 | 33,192 | 26,376 | Upgrade
|
| EBITDA Margin | 1.19% | -4.18% | -6.92% | -4.48% | 5.91% | 5.10% | Upgrade
|
| D&A For EBITDA | 26,403 | 28,319 | 29,545 | 29,311 | 27,663 | 27,919 | Upgrade
|
| EBIT | -19,199 | -53,418 | -73,666 | -54,412 | 5,529 | -1,542 | Upgrade
|
| EBIT Margin | -3.18% | -8.89% | -11.55% | -9.71% | 0.98% | -0.30% | Upgrade
|
| Advertising Expenses | - | 25,846 | 37,392 | 35,757 | 35,659 | 38,182 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.